Skip to main content

Peer Review reports

From: Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

Original Submission
16 Apr 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Jan 2016 Editorially accepted
14 Jan 2016 Article published 10.1186/s12885-016-2064-0

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us